Exchange: NASDAQ·Updated 09:30 AM EST

DMAA News

News
all
press releases
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Drugs Made In America Acquisition Corp. (NASDAQ: DMAA)
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Drugs Made In America Acquisition Corp. (NASDAQ: DMAA) $HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Drugs Made In America Acquisition Corp. (NASDAQ: DMAA) PR Newswire NEW YORK, July 21, 2026 NEW...
PR Newswire
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Drugs Made In America Acquisition Corp. (NASDAQ: DMAA)
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Drugs Made In America Acquisition Corp. (NASDAQ: DMAA) $HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Drugs Made In America Acquisition Corp. (NASDAQ: DMAA) PR Newswire NEW YORK, July 21, 2026 NEW...
PR Newswire
More News
Drugs Made In America Acquisition Corp. (NASDAQ:DMAA - Get Free Report) saw a large increase in short interest during the month of April. As of April 15th, there was short interest totaling 1,465,993 shares, an increase of 8,397.5% from the March 31st total of 17,252 shares. Based on an average...
MarketBeat
Drugs Made In America Acquisition Corp. (NASDAQ:DMAA - Get Free Report) saw a large decrease in short interest in March. As of March 31st, there was short interest totaling 17,252 shares, a decrease of 30.6% from the March 15th total of 24,866 shares. Based on an average daily volume of 43,602...
MarketBeat
JPMorgan Chase & Co. bought a new stake in Drugs Made In America Acquisition Corp. (NASDAQ:DMAA - Free Report) during the 3rd quarter, according to the company in its most recent filing with the...
MarketBeat
Drugs Made In America Acquisition (NASDAQ:DMAA) Trading Down 0% - Here's Why...
MarketBeat
Clear Street Group Inc. bought a new stake in Drugs Made In America Acquisition Corp. (NASDAQ:DMAA - Free Report) in the 3rd quarter, according to the company in its most recent disclosure with the...
MarketBeat
Radcliffe Capital Management L.P. increased its stake in shares of Drugs Made In America Acquisition Corp. (NASDAQ:DMAA - Free Report) by 316.7% during the 3rd quarter, according to its most recent...
MarketBeat
Context Capital Management LLC purchased a new position in Drugs Made In America Acquisition Corp. (NASDAQ:DMAA - Free Report) during the third quarter, according to the company in its most recent...
MarketBeat
Drugs Made In America Acquisition Corp. (NASDAQ:DMAA - Get Free Report) saw a large drop in short interest in February. As of February 13th, there was short interest totaling 28,441 shares, a drop of...
MarketBeat
Drugs Made In America Acquisition (NASDAQ:DMAA) Trading 0.1% Higher - Still a Buy...
MarketBeat

Advertisement|Remove ads.